Scientists Synthesize New Compound to Fight Stomach Infections

  • Research Stash
  • News
  • 1.7K

Scientists at the Indian Institute of Technology, Gandhinagar have synthesized a new compound that may help treat stomach infections caused by common bacteria, Helicobacter pylori (H. pylori).

Srimadhavi, Gayathri, Dr. Sivapriya, Althaf, Dr. Vijay Thiruvenkatam
Srimadhavi, Gayathri, Dr. Sivapriya, Althaf, Dr. Vijay Thiruvenkatam

The inhibitor is based on an aromatic chemical compound, indole, and may help in treating H. pylori infection which is a cause for gastritis, peptic ulcers, and stomach cancers, according to researchers.

The new inhibitor synthesized by researchers targets a gene known as Inosine-5′-monophosphate dehydrogenase (IMPDH) involved in the nucleotide synthesis of H. pylori. In initial studies, the inhibitor has been found to be better than earlier known benzimidazole-based inhibitor which is poorly metabolized in the liver and is therefore not a potent drug.

For the study, scientists isolated the IMPDH gene from H. Pylori and expressed its protein. They then tested the new inhibitor on the protein. The inhibitor was found to restrict its enzyme activity. The study also showed that the inhibitor specifically targets the Inosine-5′-monophosphate dehydrogenase protein of the bacterium and not humans making it safe for human use.

 “Validating IMPDH as a drug target for H. pylori infection would be our ultimate goal. We also want to make the medicine affordable. We are collaborating with clinicians and animal model experts to take this study further,” said Dr. Sivapriya Kirubakaran, Assistant Professor at IIT-Gandhinagar and leader of research team while speaking to India Science Wire.

It is estimated that about of half of the global population may be infected with H. pylori.

While the symptoms of this infection mostly go unnoticed, it is a cause of diseases like gastritis and ulcers.  In India, the burden of this infection is almost 80% in rural areas due to poor hygiene and healthcare facilities. Currently, the infection is treated either with clarithromycin-based therapy or by a mix of this therapy and antibiotics.

Besides Dr. Kirubakaran, the study team included Kapil Juvale, Gayathri Purushothaman, Vijay Singh, Althaf Shaik, Srimadhavi Ravi, and Vijay Thiruvenkatam. The study has been paper published in journal Scientific Reports. (India Science Wire)

By Dr. Aditi Jain

Image: Wikimedia Commons

Journal Article

Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

Rate

For the study, scientists isolated the IMPDH gene from H. Pylori and expressed its protein. They then tested the new inhibitor on the protein. The inhibitor was found to restrict its enzyme activity. The study also showed that the inhibitor specifically targets the Inosine-5′-monophosphate dehydrogenase protein of the bacterium and not humans making it safe for human use.

 “Validating IMPDH as a drug target for H. pylori infection would be our ultimate goal. We also want to make the medicine affordable. We are collaborating with clinicians and animal model experts to take this study further,” said Dr. Sivapriya Kirubakaran, Assistant Professor at IIT-Gandhinagar and leader of research team while speaking to India Science Wire.

It is estimated that about of half of the global population may be infected with H. pylori.

While the symptoms of this infection mostly go unnoticed, it is a cause of diseases like gastritis and ulcers.  In India, the burden of this infection is almost 80% in rural areas due to poor hygiene and healthcare facilities. Currently, the infection is treated either with clarithromycin-based therapy or by a mix of this therapy and antibiotics.

Besides Dr. Kirubakaran, the study team included Kapil Juvale, Gayathri Purushothaman, Vijay Singh, Althaf Shaik, Srimadhavi Ravi, and Vijay Thiruvenkatam. The study has been paper published in journal Scientific Reports. (India Science Wire)

By Dr. Aditi Jain

Image: Wikimedia Commons

Journal Article

Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook.

" }
Setting Right, A Defective Heart Condition

Setting Right, A Defective Heart Condition

A pilot study by Indian researchers explored the possibility of correcting the defective structure of CASQ2. They hypothesized that by suitably introducing small external molecules called pyranones that may attach to the protein interfaces would help in stabilizing it, in turn, regulating the ion flow

  • News
  • 1.3K
Read more
Scientists Figure Out Why HIV-1C Subtype Replicates Faster

Scientists Figure Out Why HIV-1C Subtype Replicates Faster

A team of scientists from India and America have figured out why HIV-1C subtype is more prevalent than other subtypes of the virus.

  • News
  • 1.9K
Read more

Top 10 STEM Breakthrough Technologies Of 2017 – MIT Technology Review

The 'MIT Technology Review' has recently shared its top 10 breakthrough technologies of 2017.

  • News
  • 2.1K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit